The Charlson Comorbidity Index (CCI) was used to determine the severity of chronic disease and its impact, and analytical variables such as albumin, C-reactive protein (CRP), Neutrophil/Lymphocyte Index (NLI), Lymphocyte-Platelet Index (LPI) and total protein (TP), among others, were also included.<h4>Results</h4>The prevalence of probable sarcopenia was 93.9% according to the criteria for muscle strength and physical performance (EWGSOP2). The gene discussed is CRP; the disease is sarcopenia.